ALT Stock Price
Altimmune, Inc.
$2.31
-$0.12(-4.94%)
33
Overall
60
Value
--
Tech
39
Quality
Market Cap
$449.34M
Volume
5.62M
52W Range
$2.55 - $6.44
Target Price
$14.50
ALT stock price is $2.31 (-4.94% on the day), giving Altimmune, Inc. a market cap of $449.34M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ALT Stock Overview
- Price
- $2.31
- Previous close
- $2.43
- Open
- $2.40
- Market cap
- $449.34M
- P/E ratio
- -5.1
- 52-week range
- $2.55 - $6.44
- 1-year price target
- $14.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 33
About Altimmune, Inc.
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 and is headquartered in Gaithersburg, Maryland.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALT | $2.31 | -4.9% | 5.62M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |